Cytokinetics CEO Robert I. Blum sells 7,500 shares
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
CYTOKINETICS INC (CYTK) President & CEO Robert I. Blum exercised options for 7,500 common shares on November 16, 2026, at an exercise price of $10.60 per share. On the same date, he sold 5,077 shares at a weighted-average $53.22, 2,223 shares at $54.08, and 200 shares at $55.21. The transactions were reported under a Rule 10b5-1 plan. His reported option position after the exercise was 126,745 shares. Separate holdings included 2,083 shares in each of The Bridget Blum 2003 Irrevocable Trust and The Brittany Blum 2003 Irrevocable Trust; Blum disclaimed beneficial ownership in both.
Insider Trade Summary 10b5-1
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Non-Qualified Stock Option (Right to Buy) | 7,500 | $0.00 | $0.00 |
| Exercise | Common Stock | 7,500 | $10.60 | $80K |
| Sale | Common Stock F1 | 5,077 | $53.22 | $270K |
| Sale | Common Stock F2 | 2,223 | $54.08 | $120K |
| Sale | Common Stock F3 | 200 | $55.21 | $11K |
| Holding | Common Stock F4 | -- | -- | -- |
| Holding | Common Stock F5 | -- | -- | -- |
| Holding | Common Stock | -- | -- | -- |
Footnotes (5)
- F1. The reported transaction involves sale transactions from $52.80 to $53.80 per share. The weighted average price per share was $53.22. The Reporting Person undertakes to provide upon request by the SEC staff, the Issuer or a security holder of the Issuer, information regarding the number of shares sold at each separate price
- F2. The reported transaction involves sale transactions from $53.80 to $54.46 per share. The weighted average price per share was $54.08. The Reporting Person undertakes to provide upon request by the SEC staff, the Issuer or a security holder of the Issuer, information regarding the number of shares sold at each separate price
- F3. The reported transaction involves sale transactions from $54.94 to $55.59 per share. The weighted average price per share was $55.21. The Reporting Person undertakes to provide upon request by the SEC staff, the Issuer or a security holder of the Issuer, information regarding the number of shares sold at each separate price
- F4. Shares held by The Bridget Blum 2003 Irrevocable Trust, of which reporting person is a co-trustee. Reporting person disclaims any beneficial ownership interest in the Shares.
- F5. Shares held by The Brittany Blum 2003 Irrevocable Trust, of which reporting person is a co-trustee. Reporting person disclaims any beneficial ownership interest in the Shares.
Key Figures
Key Terms
Non-Qualified Stock Option financial
Rule 10b5-1 plan regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.